Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis

Published:2012-03-23 Issue:3 Volume:17 Page:467-477
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:

Author:

HOMMA SAKAE,AZUMA ARATA,TANIGUCHI HIROYUKI,OGURA TAKASHI,MOCHIDUKI YOSHIRO,SUGIYAMA YUKIHIKO,NAKATA KOICHIRO,YOSHIMURA KUNIHIKO,TAKEUCHI MASAHIRO,KUDOH SHOJI,

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1843.2012.02132.x/fullpdf

Reference37 articles.

1. American Thoracic Society/European Respiratory Society International multidisciplinary consensus classification of the idiopathic interstitial pneumonias;American Thoracic Society/European Respiratory Society;Am. J. Respir. Crit. Care Med.,2002

2. Antioxidant therapy for idiopathic pulmonary fibrosis;Hunninghake;N. Engl. J. Med.,2005

3. Glutathione deficiency in the epithelial lining fluid of the lower respiratory in idiopathic pulmonary fibrosis;Cantin;Am. Rev. Respir. Dis.,1989

4. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis;Borok;Lancet,1991

5. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy;Glissen;Respir. Med.,1998

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-Delivery of Astaxanthin and siTGF-β1 via Ionizable Liposome Nanoparticles for Improved Idiopathic Pulmonary Fibrosis Therapy;ACS Applied Materials & Interfaces;2024-04-10

2. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series;Brain, Behavior, & Immunity - Health;2024-03

3. A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials;BMC Pulmonary Medicine;2024-01-27

4. Efficacy and Safety of Hydrogen Therapy in Patients with Early-Stage Interstitial Lung Disease: A Single-Center, Randomized, Parallel-Group Controlled Trial;Therapeutics and Clinical Risk Management;2023-12

5. A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2023-12-01